Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.
about
Modern approaches to HLA-haploidentical blood or marrow transplantationSafety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors.Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantationAllogeneic transplantation across the HLA barriers.Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignanciesHaematopoietic growth factors in children with neutropenia.Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantationImpact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell productsImmunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity.Dendritic cells in allogeneic hematopoietic stem cell transplantation.Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors.Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Recent advances on cellular therapies and immune modulators for graft-versus-host disease.T cell depleted haploidentical transplantation: positive selection.Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function.Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation.Clinical uses of GM-CSF, a critical appraisal and update.Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study.Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients.SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies.Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.Immunotherapy against invasive fungal diseases in stem cell transplant recipients.Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia.Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation
P2860
Q26797506-5215EFB9-D49B-4B99-B7B9-880A74F1EBFEQ33348605-2CB8A55C-5AF0-4F1C-AB53-5619BCD74ED7Q33358178-1F817869-DED3-4D5A-B3D3-D51A3CA7DB60Q33597783-C77F72AC-F50C-44C0-9AE5-AFEF0A8ED4B3Q34326710-AFBB201D-6746-4651-8312-4715EEFDB0FBQ34353567-34C7023E-49C6-48C9-9450-1008A8B2881BQ34527650-42EAFFED-A0C2-4BEC-8D2A-C67FACE95D48Q34834459-0AA9DA4A-735E-43F4-833B-1A1D50FB3038Q35485612-93E32D25-3915-4EB5-935C-F1EBD07729F0Q35848659-6F6E9A8F-EE59-4482-8156-78DA5BEB9EADQ36082845-3E832BAF-3CA4-43B0-9389-01AC3CEECB94Q36099441-E4CACD5F-B63E-454E-A068-566461965F3AQ36272587-36AEE3AB-35E3-427D-8FE3-832DA3F844D9Q36557963-8793DAA0-318F-464D-9B48-887B4EA66FB5Q37051052-684619F0-25A3-4BAA-BE8F-6012D3B06A4CQ37235006-FE3A8E73-C9AD-41DE-9DE9-D143C2517B52Q37381690-7C7FCEB6-89D5-4A4C-8D05-9BF54C900E0DQ38067451-812CFE8E-59F3-48C3-B40D-435815221AF3Q38246755-361B6BE0-2E75-400C-ADDC-C50C0B96F901Q38912466-67B6203F-BCCC-4FBC-82C1-6B7362D3B0ACQ40550711-ADC69FFA-01A3-47ED-A54A-9BB5174D8261Q42007990-8EDB19E1-0EA9-4D79-9287-B441590B595CQ43068695-5852ABBE-CBD1-46CA-B328-7BF861CCBCCEQ43864374-09FB39AC-ECBA-4CD2-8650-D610E78CEC2FQ44351357-93441FE1-DB35-4928-8151-961C0C348536Q44723585-107D5D81-D0A6-4266-B5B8-31750B982E61Q47235713-3A4C4BDF-80EF-419F-9BB6-574F58D80431Q47359644-5F911A2E-048E-4C03-8F43-5227A78E5C36Q47819080-78CD41A3-E81C-44BD-A594-069846D45B7FQ53152606-8C26259F-B6BE-4E3F-854C-E79B6BEFABE4Q53656699-337C518A-9D05-4DAD-8D45-AA34BB48153AQ57217484-08669F0E-4839-4EED-9BEB-BDAE20733C26
P2860
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Postgrafting administration of ...... hed hematopoietic transplants.
@en
Postgrafting administration of ...... hed hematopoietic transplants.
@nl
type
label
Postgrafting administration of ...... hed hematopoietic transplants.
@en
Postgrafting administration of ...... hed hematopoietic transplants.
@nl
prefLabel
Postgrafting administration of ...... hed hematopoietic transplants.
@en
Postgrafting administration of ...... hed hematopoietic transplants.
@nl
P2093
P356
P1433
P1476
Postgrafting administration of ...... hed hematopoietic transplants.
@en
P2093
Martelli MF
Perruccio K
P304
P356
10.1182/BLOOD.V97.8.2514
P407
P577
2001-04-01T00:00:00Z